An existing drug already used to treat other conditions could potentially be used to treat patients who have newly been diagnosed with type 1 diabetes . The drug, Rituxa, is currently used to treat rheumatoid arthritis and Hodgkin’s Lymphoma.
The potential type 1 diabetes drug is produced by Genentech – a unit of Roche Holding AG and Biogen Idec Inc. The diabetes drug could help patients to produce their own insulin, even if the pancreatic beta cells have already been attacked and destroyed.
The drug is currently under trial for diabetic use. Dr. Mark Pescovitz, the lead researcher of the study, was reported as saying: “What this study does is open the door to a whole new way to approaching type 1 diabetes.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…